L26/P-301 A microfluidic chip for standardized, rapid oocyte denudation with preserved morphology and intact mouse embryo assay outcomes
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von R. Kowsari und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can a microfluidic platform accelerate oocyte denudation while maintaining procedural safety compared with conventional manual repeated pipetting? Summary answer The microfluidic device achieved denudation 40% faster than the conventional method, with 100% recovery, preserved morphology, and no difference in Mouse Embryo Assay blastocyst rates. What is known already Oocyte denudation is routinely performed using enzymatic digestion combined with manual pipetting, a time-sensitive and labor-intensive technique requiring extensive operator training. Variability in handling can subject oocytes to uneven mechanical stress and non-uniform enzyme exposure, which has been associated with reduced oocyte survival and compromised fertilization and embryo development. While the use of microfluidics in in vitro fertilization (IVF) laboratories is increasing, safe, standardized, and automation-compatible solutions for oocyte denudation remain limited. Study design, size, duration Mature metaphase II (MII) oocytes were collected from female B6D2F1 mice and used within one hour. Apart from counting cumulus–oocyte complexes (COCs), no additional processing was performed prior experiment. A total of 96 COCs were allocated to a microfluidic group (n = 64) or a control group (n = 32). Conventional denudation was performed in parallel. Statistical analyses were performed using t-test for time per oocyte and Chi-square test for blastocyst rate. Participants/materials, setting, methods COCs were processed in three independent batches in a closed custom-made PDMS microfluidic device. Conventional denudation was performed by exposing the COCs to the same enzyme concentration followed by manual pipetting. Denudation time, recovery rate, efficiency, blastocyst rate, and morphological integrity were evaluated. Procedural safety was assessed using Mouse Embryo Assay (MEA) on 2-cell embryos collected from female B6D2F1 mice, in accordance with U.S. Food and Drug Administration guidance. Main results and the role of chance The microfluidic platform achieved complete denudation of oocytes with a mean processing time of 15 seconds per oocyte, approximately 40% faster than the conventional manual method (p < 0.001). The total run time was 300 seconds (60 seconds of treatment with 87 IU/mL hyaluronidase, 20 seconds of washing, 200 seconds of denudation, and 20 seconds of collection), corresponding to approximately 15 seconds per oocyte. Denudation efficiency was 100% across three independent replicates. Additionally, no oocytes were lost in the chip, yielding a 100% recovery rate. Oocyte morphology was preserved following denudation, with no increase in zona pellucida damage or cytoplasmic abnormalities compared with the control group. To further assess procedural safety, the same microfluidic workflow was applied to mouse 2-cell embryos (n = 63), which were subsequently cultured in Petri dishes. No difference in blastocyst development rates was observed between embryos processed in the microfluidic device and the unprocessed Petri dish control group. Specifically, 100% (38/38) of embryos in the microfluidic group and 100% (25/25) of embryos in the Petri dish group developed into full blastocysts after 96 hours of culture in M16 medium. Limitations, reasons for caution This study was conducted in a mouse model and did not assess fertilization, implantation, or live birth outcomes, nor was any clinical human evaluation conducted. Wider implications of the findings This microfluidic approach may enable procedurally safer, faster, and more standardized oocyte denudation and represents a step toward fully automated denudation and IVF platforms. Trial registration number No
Zitieren
APA
Kowsari, R., Fage, F., Banrezes, B., Dupont, C., Levy, R., Haliyo, S., Lameignère, E., & Gerena, E. (2026). L26/P-301 A microfluidic chip for standardized, rapid oocyte denudation with preserved morphology and intact mouse embryo assay outcomes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.637
Vancouver
Kowsari R, Fage F, Banrezes B, Dupont C, Levy R, Haliyo S, et al. L26/P-301 A microfluidic chip for standardized, rapid oocyte denudation with preserved morphology and intact mouse embryo assay outcomes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.637
BibTeX
@article{Kowsari2026,
author = {Kowsari, R. and Fage, F. and Banrezes, B. and Dupont, C. and Levy, R. and Haliyo, S. and Lameignère, E. and Gerena, E.},
title = {L26/P-301 A microfluidic chip for standardized, rapid oocyte denudation with preserved morphology and intact mouse embryo assay outcomes},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.637}
}
EUVIMED